Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

In patients with acute coronary syndromes, low doses of rivaroxaban were effective in reducing the primary end point of death from cardiovascular causes, myocardial infarction, or stroke. Rivaroxaban also reduced overall mortality, although there was more bleeding. After an acute coronary syndrome,...

Full description

Saved in:
Bibliographic Details
Published in:The New England journal of medicine Vol. 366; no. 1; pp. 9 - 19
Main Authors: Mega, Jessica L, Braunwald, Eugene, Wiviott, Stephen D, Bassand, Jean-Pierre, Bhatt, Deepak L, Bode, Christoph, Burton, Paul, Cohen, Marc, Cook-Bruns, Nancy, Fox, Keith A.A, Goto, Shinya, Murphy, Sabina A, Plotnikov, Alexei N, Schneider, David, Sun, Xiang, Verheugt, Freek W.A, Gibson, C. Michael
Format: Journal Article
Language:English
Published: Waltham, MA Massachusetts Medical Society 05.01.2012
Subjects:
ISSN:0028-4793, 1533-4406, 1533-4406
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first